Header cover image

Swedish (OMX) Life Sciences Industry Analysis

UpdatedAug 02, 2024
DataAggregated Company Financials
Companies12
  • 7D1.7%
  • 3M25.5%
  • 1Y54.2%
  • YTD30.0%

Biotage is up 2.7%, leading the way for the Life Sciences industry, which has gained 1.7%. In the last 12 months, the industry was up 54%. As for the next few years, earnings are expected to grow by 46% per annum.

Industry Valuation and Performance

Has the Swedish Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 03 Aug 2024SEK 49.2bSEK 16.7b-SEK 1,128,120,510.0061.9x-43.6x2.9x
Mon, 01 Jul 2024SEK 42.0bSEK 16.3b-SEK 1,188,686,510.0055.3x-35.3x2.6x
Wed, 29 May 2024SEK 42.2bSEK 16.3b-SEK 1,188,686,510.0060.3x-35.5x2.6x
Fri, 26 Apr 2024SEK 37.0bSEK 16.3b-SEK 1,244,732,213.0035.5x-29.7x2.3x
Sun, 24 Mar 2024SEK 38.8bSEK 16.0b-SEK 1,122,792,210.0036x-34.6x2.4x
Tue, 20 Feb 2024SEK 40.8bSEK 16.1b-SEK 1,406,407,350.0047.3x-29x2.5x
Thu, 18 Jan 2024SEK 36.4bSEK 15.5b-SEK 1,393,723,683.0044x-26.1x2.4x
Sat, 16 Dec 2023SEK 38.2bSEK 15.5b-SEK 1,393,723,683.0047.6x-27.4x2.5x
Mon, 13 Nov 2023SEK 31.2bSEK 15.4b-SEK 1,256,647,710.0034x-24.8x2x
Wed, 11 Oct 2023SEK 26.5bSEK 15.1b-SEK 1,134,516,711.0035.7x-23.4x1.8x
Fri, 08 Sep 2023SEK 29.2bSEK 15.1b-SEK 1,133,713,072.0038.1x-25.8x1.9x
Sun, 06 Aug 2023SEK 32.1bSEK 15.1b-SEK 213,871,038.0046.7x-150.2x2.1x
Tue, 04 Jul 2023SEK 36.3bSEK 14.6b-SEK 172,476,038.0035.9x-210.7x2.5x
Thu, 01 Jun 2023SEK 38.8bSEK 14.6b-SEK 173,602,038.0038.8x-223.4x2.6x
Sat, 29 Apr 2023SEK 36.4bSEK 14.5b-SEK 138,425,459.0035x-262.9x2.5x
Mon, 27 Mar 2023SEK 31.9bSEK 14.6b-SEK 57,185,459.0031x-557.6x2.2x
Wed, 22 Feb 2023SEK 40.2bSEK 14.4bSEK 826.4m35.4x48.6x2.8x
Fri, 20 Jan 2023SEK 38.5bSEK 14.2bSEK 943.9m38.1x40.8x2.7x
Sun, 18 Dec 2022SEK 39.4bSEK 14.1bSEK 944.3m41.5x41.7x2.8x
Tue, 15 Nov 2022SEK 39.6bSEK 14.1bSEK 936.8m41.4x42.3x2.8x
Thu, 13 Oct 2022SEK 32.3bSEK 13.5bSEK 750.9m47.7x42.9x2.4x
Sat, 10 Sep 2022SEK 38.4bSEK 13.5bSEK 751.3m55.5x51.1x2.8x
Mon, 08 Aug 2022SEK 43.7bSEK 13.2bSEK 667.8m44.6x65.4x3.3x
Wed, 06 Jul 2022SEK 44.7bSEK 13.2bSEK 753.4m39.3x59.3x3.4x
Fri, 03 Jun 2022SEK 54.8bSEK 13.2bSEK 753.4m48.2x72.8x4.1x
Sun, 01 May 2022SEK 53.3bSEK 12.7bSEK 742.5m51.9x71.8x4.2x
Tue, 29 Mar 2022SEK 61.7bSEK 11.8bSEK 746.3m54.4x82.6x5.2x
Thu, 24 Feb 2022SEK 50.6bSEK 11.4bSEK 784.8m43.3x64.5x4.4x
Sat, 22 Jan 2022SEK 66.8bSEK 10.8bSEK 786.3m44.8x85x6.2x
Mon, 20 Dec 2021SEK 79.5bSEK 10.8bSEK 786.3m51.5x101.1x7.4x
Wed, 17 Nov 2021SEK 88.7bSEK 10.8bSEK 788.5m54.4x112.4x8.2x
Fri, 15 Oct 2021SEK 93.7bSEK 9.9bSEK 853.6m55.4x109.8x9.5x
Sun, 12 Sep 2021SEK 102.5bSEK 9.9bSEK 853.6m58.5x120.1x10.4x
Tue, 10 Aug 2021SEK 90.3bSEK 9.9bSEK 853.6m48.7x105.8x9.2x
Price to Earnings Ratio

105.8x


Total Market Cap: SEK 90.3bTotal Earnings: SEK 853.6mTotal Revenue: SEK 9.9bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Life Sciences Industry Price to Earnings3Y Average -27.1x202220232024
Current Industry PE
  • Investors are pessimistic on the Swedish Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 3.8x is higher than the industry's current PS ratio of 2.9x.
Past Earnings Growth
  • Total earnings for the Life Sciences industry have declined over the last three years, with the industry now making a loss overall.
  • Meanwhile revenues have grown 19% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare industry?

SE Market-0.60%
Healthcare-2.40%
Life Sciences1.70%
Clinical Research and Equipment1.70%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
PRO PromimicSEK 35.800.8%
+SEK 5.6m		22.2%PS15.9x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

MAGLE

SEK 41.00

Magle Chemoswed Holding

7D

-8.9%

1Y

18.5%

ALIF B

SEK 150.10

AddLife

7D

-3.5%

1Y

80.4%

AddLife AB (publ) (STO:ALIF B) Surges 26% Yet Its Low P/S Is No Reason For Excitement

Jul 26
AddLife AB (publ) (STO:ALIF B) Surges 26% Yet Its Low P/S Is No Reason For Excitement

MCAP

SEK 547.00

MedCap

7D

-7.4%

1Y

75.9%

PEXA B

SEK 0.37

PExA

7D

-5.6%

1Y

-30.1%

BIOT

SEK 188.60

Biotage

7D

-2.1%

1Y

49.7%

BICO

SEK 39.06

BICO Group

7D

-9.5%

1Y

-9.3%

GENO

SEK 28.05

Genovis AB (publ.)

7D

-4.4%

1Y

-39.3%

PRO

SEK 35.80

Promimic

7D

0.8%

1Y

22.2%

LEVBIO

SEK 0.32

Level Bio

7D

-14.3%

1Y

-49.4%